MedTrace Logo

Brain Network Modulation and Alcohol Use

NCT04828577 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2026-02-10

Study results available
· View outcomes & findings →

Summary

The investigators will use real-time fMRI neurofeedback to enhance participants' ability to control their ability to modulate alcohol valuation.

Conditions

  • Alcohol Use Disorder (AUD)

Interventions

BEHAVIORAL

Real Time Neurofeedback

Participants receive feedback from their own brain activity.

Sponsors & Collaborators

  • Fralin Biomedical Research Institute

    collaborator UNKNOWN

  • Virginia Polytechnic Institute and State University

    lead OTHER

Principal Investigators

  • Stephen M LaConte, PhD · Fralin Biomedical Research Institute (FBRI) at VTC

  • Warren K Bickel, PhD · Fralin Biomedical Research Institute (FBRI) at VTC

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-13
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04828577 on ClinicalTrials.gov